PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.96%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-36.13%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-206.50%
Negative EBIT growth while MTDR is at 54.34%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-206.50%
Negative operating income growth while MTDR is at 54.34%. Joel Greenblatt would press for urgent turnaround measures.
38.07%
Net income growth at 50-75% of MTDR's 53.28%. Martin Whitman would question fundamental disadvantages in expenses or demand.
38.02%
EPS growth at 50-75% of MTDR's 53.68%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
38.57%
Diluted EPS growth at 50-75% of MTDR's 53.33%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.10%
Share reduction while MTDR is at 0.71%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.81%
Diluted share change of 0.81% while MTDR is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-66.63%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-64.96%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-220.24%
Negative FCF growth while MTDR is at 10.22%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-81.09%
Negative 10Y revenue/share CAGR while MTDR stands at 140.84%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-60.51%
Negative 5Y CAGR while MTDR stands at 61.16%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-38.33%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-91.99%
Negative 10Y OCF/share CAGR while MTDR stands at 1.13%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-78.32%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-59.71%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-130.15%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-524.79%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
23.73%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
-61.08%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-71.55%
Negative 5Y equity/share growth while MTDR is at 2.87%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
1.55%
Positive short-term equity growth while MTDR is negative. John Neff sees a strong advantage in near-term net worth buildup.
-76.18%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.27%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-92.33%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-36.84%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-2.82%
Negative asset growth while MTDR invests at 2.04%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-10.64%
We have a declining book value while MTDR shows 6.65%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.00%
Debt growth far above MTDR's 0.08%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.85%
We cut SG&A while MTDR invests at 13.65%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.